These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17300254)

  • 1. Acute necrotic pancreatitis induced by severe hypercalcaemia due to tacalcitol ointment.
    Knackstedt C; Winograd R; Koch A; Abuzahra F; Trautwein C; Wasmuth HE
    Br J Dermatol; 2007 Mar; 156(3):576-7. PubMed ID: 17300254
    [No Abstract]   [Full Text] [Related]  

  • 2. Iatrogenic hypercalcemia due to vitamin D3 ointment (1,24(OH)2D3) combined with thiazide diuretics in a case of psoriasis.
    Kawaguchi M; Mitsuhashi Y; Kondo S
    J Dermatol; 2003 Nov; 30(11):801-4. PubMed ID: 14684937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current experience with tacalcitol ointment in the treatment of psoriasis.
    Gollnick H; Menke T
    Curr Med Res Opin; 1998; 14(4):213-8. PubMed ID: 9891193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of clinical efficacy and safety of topical tacalcitol.
    Leone G; Pacifico A
    Acta Biomed; 2005 Apr; 76(1):13-9. PubMed ID: 16116820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic contact dermatitis from tacalcitol.
    Kimura K; Katayama I; Nishioka K
    Contact Dermatitis; 1995 Dec; 33(6):441-2. PubMed ID: 8706417
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment.
    Braun GS; Witt M; Mayer V; Schmid H
    Int J Dermatol; 2007 Dec; 46(12):1315-7. PubMed ID: 18173537
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe hypercalcemia and hypernatremia associated with calcipotriol for treatment of psoriasis.
    Kawahara C; Okada Y; Tanikawa T; Fukusima A; Misawa H; Tanaka Y
    J Bone Miner Metab; 2004; 22(2):159-62. PubMed ID: 14999528
    [No Abstract]   [Full Text] [Related]  

  • 8. Freckling promoted by topical tacalcitol in a Japanese boy with left eyelid vitiligo.
    Oiso N; Kawada A
    Pediatr Dermatol; 2012; 29(5):671-2. PubMed ID: 22011021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled evaluation of the irritant potential of tacalcitol (1a,24-dihydroxyvitamin D3) in healthy volunteers.
    Schlotmann K; Ortland C; Neumann NJ; Ruzicka T; Lehmann P
    Contact Dermatitis; 2000 May; 42(5):260-3. PubMed ID: 10789839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
    Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
    Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients.
    Prignano F; Buggiani G; Lotti T
    Acta Biomed; 2009 Apr; 80(1):51-6. PubMed ID: 19705621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
    Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe neutrophilia induced by infliximab for psoriasis.
    de Oliveira JP; Levy A; Morel P; Guibal F
    Br J Dermatol; 2008 Jan; 158(1):200-1. PubMed ID: 18028489
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between paclitaxel and necrotic pancreatitis.
    McMahon MA; Kearns G; McCaffrey J; Grogan L
    Ir Med J; 2006 Oct; 99(9):281. PubMed ID: 17144240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia and increases in serum hormone value during prolonged administration of 1alpha,25-dihydroxyvitamin D.
    Bell NH; Stern PH
    N Engl J Med; 1978 Jun; 298(22):1241-3. PubMed ID: 651964
    [No Abstract]   [Full Text] [Related]  

  • 16. First case report of topical tacalcitol for vitiligo repigmentation.
    Amano H; Abe M; Ishikawa O
    Pediatr Dermatol; 2008; 25(2):262-4. PubMed ID: 18429797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcemia during long-term treatment with 1,25-dihydroxyvitamin D3 in hypoparathyroidism.
    Bell NH; Epstein S; Stern PH
    N Engl J Med; 1979 Nov; 301(21):1183-4. PubMed ID: 492291
    [No Abstract]   [Full Text] [Related]  

  • 19. Bilateral nevus comedonicus: efficacy of topical tacalcitol ointment.
    Wakahara M; Kiyohara T; Kumakiri M; Kuwahara H; Fujita T
    Acta Derm Venereol; 2003; 83(1):51. PubMed ID: 12636024
    [No Abstract]   [Full Text] [Related]  

  • 20. Pretreatment of psoriasis with the vitamin D3 derivative tacalcitol increases the responsiveness to 311-nm ultraviolet B: results of a controlled, right/left study.
    Messer G; Degitz K; Plewig G; Röcken M
    Br J Dermatol; 2001 Mar; 144(3):628-9. PubMed ID: 11260031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.